Results 41 to 50 of about 454,943 (311)

Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial

open access: yesBMC Gastroenterology, 2021
Background This randomized, open-label trial aimed to compare the efficacy of 10-day bismuth-containing quadruple therapy (BQT) with 7-day proton-pump inhibitor-clarithromycin containing standard triple therapy (STT) as an empirical first-line ...
Young-Il Kim   +5 more
doaj   +1 more source

The role of gastric microbiota in gastric cancer [PDF]

open access: yesGut Microbes, 2020
Gastric cancer represents one of the leading causes of cancer deaths worldwide. Helicobacter pylori (H. pylori) infection is the strongest risk factor associated with gastric cancer. Due to new molecular techniques allowing greater identification of stomach microbes, investigators are beginning to examine the role that bacteria other than H.
Oliver A. Stewart, Fen Wu, Yu Chen
openaire   +3 more sources

Association between Chemotherapy-Response Assays and Subsets of Tumor-Infiltrating Lymphocytes in Gastric Cancer: A Pilot Study [PDF]

open access: yes, 2015
PURPOSE: The purpose of this pilot study was to evaluate the association between adenosine triphosphate-based chemotherapy response assays (ATP-CRAs) and subsets of tumor infiltrating lymphocytes (TILs) in gastric cancer. MATERIALS AND METHODS: In total,
김충배   +6 more
core   +1 more source

Gastric cancer. [PDF]

open access: yesBMJ, 1992
Summary We are gaining a clearer insight into the causes and mechanisms of gastric carcinogenesis, and may be able to reduce the incidence in the future by Helicobacter pylori eradication, perhaps in conjunction with nutritional supplements.
openaire   +5 more sources

Gastrin and Gastric Cancer [PDF]

open access: yesFrontiers in Endocrinology, 2017
Gastric cancer although occurring in reduced frequency is still an important disease, partly because of the bad prognosis when occurring in western countries. This decline in occurrence may mainly be due to the reduced prevalence of Helicobacter pylori (Hp) infection, which is the most important cause of gastric cancer.
Waldum, Helge   +2 more
openaire   +3 more sources

Gastric Cancer at a University Teaching Hospital in Northwestern Tanzania: A Retrospective Review of 232 Cases. [PDF]

open access: yes, 2012
Despite marked decreases in its incidence, particularly in developed countries, gastric cancer is still the second most common tumor worldwide. There is a paucity of information regarding gastric cancer in northwestern Tanzania. This study was undertaken
Nestory Masalu   +23 more
core   +1 more source

Safe Discharge Criteria After Curative Gastrectomy for Gastric Cancer [PDF]

open access: yes, 2022
Purpose: This study aimed to investigate the relationship between clinical and laboratory parameters and complication status to predict which patients can be safely discharged from the hospital on the third postoperative day (POD). Materials and methods:
형우진   +3 more
core   +1 more source

Safety of Laparoscopic Sentinel Basin Dissection in Patients with Gastric Cancer: an Analysis from the SENORITA Prospective Multicenter Quality Control Trial. [PDF]

open access: yes, 2018
Purpose: We investigated complications after laparoscopic sentinel basin dissection (SBD) for patients with gastric cancer who were enrolled in a quality control study, prior to the phase III trial of sentinel lymph node navigation surgery (SNNS).
형우진
core   +1 more source

Construction of ovarian metastasis‐related immune signature predicting prognosis of gastric cancer patients

open access: yesCancer Medicine, 2023
Background Ovarian metastasis (OM) results in poor survival of gastric cancer (GC) patients. While immunotherapy has emerged as a promising approach for late‐stage GC, validated immune‐related prognostic signatures still remain in need. In this study, we
Jianpeng Gao   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy